STOCK TITAN

Insider plans stock sale in TNYA (Nasdaq: TNYA) shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

TNYA filed a Form 144 notice for a planned stock sale. The filing covers the proposed sale of 14,862 shares of common stock on or about February 17, 2026 through Morgan Stanley Smith Barney, with an aggregate market value of $9,556.66.

The issuer had 213,744,535 shares outstanding at the time referenced. The securities to be sold stem from a restricted stock unit acquisition of 39,688 common shares from the issuer on February 17, 2026. The signer represents they are not aware of undisclosed material adverse information about the company.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for TNYA disclose?

The Form 144 for TNYA discloses a planned sale of 14,862 shares of common stock, with an aggregate market value of $9,556.66, to be executed through Morgan Stanley Smith Barney around February 17, 2026.

How many TNYA shares are planned to be sold under this Form 144?

The filer plans to sell 14,862 shares of TNYA common stock. These shares have an indicated aggregate market value of $9,556.66 and are to be sold through Morgan Stanley Smith Barney on or about February 17, 2026.

What is the source of the TNYA shares to be sold under Form 144?

The TNYA shares to be sold come from a restricted stock unit acquisition. On February 17, 2026, the filer acquired 39,688 common shares from the issuer via RSUs, and a portion of these shares is being registered for potential sale.

How many TNYA shares were outstanding at the time referenced in the Form 144?

The Form 144 notes that 213,744,535 shares of TNYA common stock were outstanding. This figure provides context for the planned sale of 14,862 shares relative to the company’s total share count at the referenced time.

Which broker will handle the TNYA Form 144 share sale?

The planned sale of TNYA shares will be handled by Morgan Stanley Smith Barney, specifically its Operations Department in Purchase, New York. The shares are listed on the Nasdaq Global Select Market according to the filing details.

What representation does the seller make in the TNYA Form 144?

The seller represents that they do not know of any material adverse information about TNYA’s current or prospective operations that has not been publicly disclosed, consistent with the standard certification language included in Form 144 notices.
Tenaya Therapeutics, Inc.

NASDAQ:TNYA

TNYA Rankings

TNYA Latest News

TNYA Latest SEC Filings

TNYA Stock Data

136.66M
214.85M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SOUTH SAN FRANCISCO